Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORCHID: Benralizumab in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps
TCTR20190820003Phase 3Not yet recruiting
- Sponsor
- AstraZeneca
- Start
- Nov 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of benralizumab in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by AstraZeneca. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
benralizumab
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on TCTR20190820003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190820003.